Guillaume Grenet
@guillaume-grenet.bsky.social
📤 157
📥 277
📝 3
#pharmaco
#diabeto
#meta
#endocrino
#toxico
follow-up
www.bmj.com/content/389/...
Investigation "Ticagrelor doubts: inaccuracies uncovered in key studies for AstraZeneca’s billion dollar drug", BMJ 2025
add a skeleton here at some point
8 months ago
0
0
0
"Drug Versioning and Legal Accountability for Preventable Product Harms", Viewpoint in JAMA 2025
jamanetwork.com/journals/jam...
loading . . .
Drug Versioning and Legal Accountability for Preventable Product Harms
This Viewpoint discusses drug versioning and legal accountability for preventable product harms.
https://jamanetwork.com/journals/jama/fullarticle/2831386?utm_source=twitter&utm_campaign=content-shareicons&utm_content=article_engagement&utm_medium=social&utm_term=050725
10 months ago
0
1
0
reposted by
Guillaume Grenet
Société Française de Pharmacologie et de Thérapeutique
10 months ago
La FAQ concernant la Formation Spécialisée Transversale (FST) Pharmacologie Médicale et Thérapeutique (PMT) vient d'être mise à jour! Retrouvez là ici (site du CNPM)
pharmacomedicale.org/les-formatio...
loading . . .
La FST Pharmacologie Médicale et Thérapeutique (PMT)
Permet aux étudiants, professionnels de santé, et au grand public, d'accéder librement à une information sur le médicament validée par les pharmacologues médica
https://pharmacomedicale.org/les-formations/fst-pmt/281-la-fst-pharmacologie-medicale-et-therapeutique-pmt
0
7
4
reposted by
Guillaume Grenet
The BMJ
about 1 year ago
The US was considered a world leader in public health and research. With one repressive stroke that reputation risks being broken, argue
@jocalynclark.bsky.social
and
@kamranabbasi.bsky.social
www.bmj.com/content/388/...
7
100
67
reposted by
Guillaume Grenet
Therapeutics Initiative (TI)
about 1 year ago
@ubcpublichealth.bsky.social
is looking for a post-doc to join a national research program on community antibiotic stewardship! Don't miss out!
ubc.wd10.myworkdayjobs.com/ubcfacultyjobs
loading . . .
UBC - One of the World's Leading Universities As one of the world's leading universities, the University of British Columbia creates an exceptional learning environment that fosters global citizenship, advances a civil and sustainable society, and supports outstanding research to serve the people of British Columbia, Canada and the world. UBC hires on the basis of merit and is committed to employment equity. All qualified persons are encouraged to apply. Equity and diversity are essential to academic excellence. An open and diverse community fosters the inclusion of voices that have been underrepresented or discouraged. We encourage applications from members of groups that have been marginalized on any grounds enumerated under the B.C. Human Rights Code, including sex, sexual orientation, gender identity or expression, racialization, disability, political belief, religion, marital or family status, age, and/or status as a First Nation, Metis, Inuit, and/or Indigenous person. All qualified candidates are encouraged to apply; however Canadians and permanent residents will be given priority. If you have any accommodation or accessibility needs during the job application process, please contact the Centre for Workplace Accessibility at
[email protected]
.
https://ubc.wd10.myworkdayjobs.com/ubcfacultyjobs
0
1
2
reposted by
Guillaume Grenet
Société Française de Pharmacologie et de Thérapeutique
about 1 year ago
Nouveau
#pharmacofact
sur notre site : Il porte sur le mésusage et la désinformation autour du bleu de méthylène, présenté récemment, sans base factuelle, comme remède miracle du cancer par plusieurs publications et médias destinés au grand public.
sfpt-fr.org/pharmacofact...
@lexpress.bsky.social
loading . . .
#F023 Mésusage et désinformation autour du bleu de méthylène
Société Française de Pharmacologie et de Thérapeutique
https://sfpt-fr.org/pharmacofact-blog/2110-f023-mesusage-et-desinformation-bleu-de-methylene
0
22
12
reposted by
Guillaume Grenet
Stéphanie Benz
about 1 year ago
Du bleu de méthylène contre le cancer ? Face aux étranges recommandations du Dr Laurent Schwartz,
@drbarriere.bsky.social
et @mathieumolimard.bsky.social de la
@sfpt-fr.org
lancent l’alerte. A lire sur
@lexpress.bsky.social
✒️
@antoinebeau.bsky.social
👇
www.lexpress.fr/sciences-san...
loading . . .
Du bleu de méthylène contre le cancer ? Les étranges recommandations du Dr Schwartz
Livres, entretiens, conférences… Le cancérologue Laurent Schwartz assure, sans le démontrer, qu’il a découvert un remède universel aux tumeurs. Selon nos informations, l’Ordre des médecins a été saisi...
https://www.lexpress.fr/sciences-sante/du-bleu-de-methylene-contre-le-cancer-les-etranges-recommandations-du-dr-schwartz-FGA2MVYUURCWJAVT2TCXZ3463U/
0
22
13
reposted by
Guillaume Grenet
Fundamental and Clinical Pharmacology Journal (SFPT)
about 1 year ago
SFPT annual meeting 2025 - 24-26th of June Abstract submission deadline extended to 12th of January!
www.congres-sfpt.fr/abstract.asp...
#SFPT
#pharmacology
#medication
#cardiovascular
#oncology
#pharmacoepidemiology
#pharmacovigilance
#pharmacogenetic
loading . . .
Congrès SFPT 2025
https://www.congres-sfpt.fr/abstract.aspx?e=1819&culture=fr-FR
0
1
3
reposted by
Guillaume Grenet
Therapeutics Initiative (TI)
about 1 year ago
🆕
#BestEvidence
webinar recording 😍 Safe & sound: Polypharmacy & rational primary care
ti.ubc.ca/drugevidence24
Dr. Dee Mangin describes vital aspects of primary care in maximizing therapeutic benefit + provides examples/areas of challenge for rational treatment
#DrugEvidence24
#medsky
#pharmsky
0
8
7
reposted by
Guillaume Grenet
JAMA
about 1 year ago
While glucagon prescriptions for severe hypoglycemia in Medicaid decreased between 2012 and 2018, they increased from 2019 to 2023 with the introduction of newer, easier-to-use glucagon products.
ja.ma/4jaCKfm
0
11
2
reposted by
Guillaume Grenet
JAMA
about 1 year ago
Treatment of gestational diabetes with metformin and additional glyburide, if needed, was not noninferior to insulin in preventing infants from being born large for gestational age.
#MedSky
ja.ma/40mVHEk
1
14
4
reposted by
Guillaume Grenet
NEJM.org
about 1 year ago
The OCEANIC-AF randomized trial of the factor XIa inhibitor asundexian was stopped early owing to a higher incidence of stroke or systemic embolism than with apixaban therapy among patients with atrial fibrillation. Full trial results:
nej.md/473TRdc
#MedSky
0
11
8
reposted by
Guillaume Grenet
Clara Locher
about 1 year ago
Premier Winter Camp de la
@sfpt-fr.org
« décider à partir des études clinique » : les inscriptions ouvertes !
sfpt-fr.org?view=article...
0
6
5
reposted by
Guillaume Grenet
Société Française de Pharmacologie et de Thérapeutique
about 1 year ago
Communiqué de presse de la SFPT: Rétractation de l’étude Gautret et coll. (Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial) : une page sombre de la recherche sur la COVID-19 enfin tournée . A lire 👉
sfpt-fr.org/vie-de-la-sf...
1
59
29
www.bmj.com/content/387/...
loading . . .
Doubts over landmark heart drug trial: ticagrelor PLATO study
A top selling antiplatelet drug has never quite shaken off doubts about its advantage over cheaper rivals. With generic versions of ticagrelor about to launch, Peter Doshi takes a fresh look at the ev...
https://www.bmj.com/content/387/bmj.q2550
about 1 year ago
0
3
2
you reached the end!!
feeds!
log in